Reportedly, galactose provides an alternative carbohydrate source and improved homeostatic regulation of glucose in the premature infant. Because of its potentially toxic effects, sensitive methods are needed for monitoring its concentration during therapy. We evaluated an immobilized galactose oxidase/hydrogen peroxide electrode system and a modified homogeneous enzymic method. Both methods are suitable for measuring galactose in a small sample and are comparably precise. The latter method gives superior analytical recoveries below 100 mg/L, but is linear in absorbance response to only 300 mg/L. We find the immobilized-enzyme method superior for monitoring treatment of neonates with galactose, because it requires only a few minutes and 25 L of serum, and the analytical procedure is simpler.
Glucose intolerance during the first few postnatal months, especially in premature infants, is a well-recognized clinical finding (1) . It was shown in rats that simultaneous administration of glucose and galactose can increase available calories and aid in the regulation of glucose metabolism (2) . Further studies now indicate that galactose can provide an alternative carbohydrate source and can improve homeostatic regulation of glucose metabolism in neonates (1) . The concentration of galactose in serum on infusion of the glucose-galactose solution is monitored in newborns to help prevent the untoward effects of too-high galactose concentrations.
Methods involving the use of galactose oxidase (EC 1.1.3.9)
were described as early as 1960 and provided significant advantages over less-specific methods based on the measurement of reducing substances (3) (4) (5) . An enzymic method for measurement of galactose is based on the following coupled reactions: Various chromogens-including benzidine, o-dianisidine, and o-cresol-have been used in this technique (6) (7) (8) . Galactose may also be measured by an enzymic method (9) galactose dehydrogenase (EC 1.1.1.48):
This methodology has been adapted to a centrifugal analyzer and allows automated analysis of microsamples (10).
We describe here results obtained by a manual enzymic method and our evaluation of a solid-phase enzymic procedure for measuring galactose in serum. We used a Model 55 spectrophotometer (Perkin-Elmer
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Corp., Norwalk, CT 06856).
Reagents
The buffered (pH 7.3) reagent for the galactose analyzer contains, per liter, 15 mmol of NaH2PO4, 55 mmol of Na2HPO4, 53 mmol of NaCI, 7 mmol of C6H5COONa, 72 mg of catalase (EC 1.11.1.6; 5000 U/g), 0.33 mmol of Na3Fe(CN)6 H20, and 11.7 smol of CuCl2. 2H20. Galactose oxidase immobilized between cellulose acetate polycarbonate membranes was provided by Yellow Springs Instrument
Co. (4).
These membranes can be used for three to six weeks, regardless of the number of assays run. Reagent kits for measuring galactose were obtained from Worthington Biochemicals, Freehold, NJ 07728, and the procedure was modified to increase the sensitivity of the assay between 20 and 300 mg/L and to accommodate 25-sL samples, as follows. The contents of vial A, containing the enzymes, were diluted with 5 mL of 10 mmol/L tris(hydroxymethyl)aminomethane, pH 7.4, and 100 1zL of 21 g/L Triton X-100 surfactant. Vial B, containing the chromogen, was diluted with 5 mL of the buffer.
Procedures
Galactose analyzer: Set the zero response by injecting water only. Use a 1000 mg/L galactose standard (Sigma Chemical Co., St. Louis, MO 63178) prepared in de-ionized water to calibrate the instrument. About 2 to 3 mm is required for each analysis. The sample volume is 25 .sL of serum. All steps in the analysis are identical to those described for measurement of glucose (5) .
Manual enzymic method:
Use a 100-tL aliquot of serum to prepare a protein-free solution.
To each serum sample add We evaluated the linearity of each method by adding ga- the mean recoveries for galactose in the presence of glucose (up to 2000 mgfL) or uric acid (up to 160 mg/L) were 98 and 95%, respectively. For the manual method, these values were 102 and 99%, respectively.
We evaluated the effects of fructose, ascorbic acid, bilirubin, and hemoglobin on the measurement of galactose with the galactose analyzer. Fructose and ascorbic acid up to 2000 mg/L and 40 mg/L, respectively, had no effect on the electrode system. Bilirubin (300 mgfL) and hemoglobin (500 mg/L) were added separately to serum containing from 0 to 350 mg/L of galactose. The mean analytical recoveries were 96 and 104%, respectively.
A comparison of results by both the manual method (x) and the galactose analyzer (y) for 17 sera from neonates gave the regression equation y = 1.04x + 10.5, a correlation coefficient of 0.735, and a standard error of the estimate of 35.6 mg/L. Additional evaluation of the data with the Sign test and the Wilcoxon signed rank test showed no significant difference in results by the two methods (p <0.05). The high standard error of the estimate most likely reflects day-to-day variation in the manual method.
In pre-term neonates who were receiving a galactose-contaming formula by mouth, the galactose values ranged from 4.9 mg/L to undetectable ( = 1 mg/L). In another preterm population receiving a glucose-galactose infusion (50 g of each per liter), the galactose concentration ranged from 29 mg/L to less than 1 mg/L (1 = 11 mg/L). The immobilized-enzyme system for measuring galactose was as precise as the manual procedure, but for concentrations below 100 mg/L the galactose analyzer generally gave lower analytical recoveries than did the manual enzymic method. Although recoveries could no doubt have been improved-for example, by using a larger sample size-better recovery is not required for the instrumental method in this range, because only the higher galactose concentrations are of major interest.
The manual procedure appears to be more sensitive for galactose concentrations below 100 mg/L.
The wider range of linearity of the immobilized-enzyme method makes it more easily applicable to different clinical and industrial applications.
Sample preparation, time required for analysis, and convenience all make the immobilized-enzyme method superior to the manual procedure. We recommend it for neonatal testing when galactose is being used as a carbohydrate supplement.
